DAWNRAYS - Trademark Details
Status: 404 - U.S. registration cancelled because International Registration cancelled in whole or in part
Image for trademark with serial number 79084679
Serial Number
79084679
Registration Number
4219862
Word Mark
DAWNRAYS
Status
404 - U.S. registration cancelled because International Registration cancelled in whole or in part
Status Date
2020-04-27
Filing Date
2010-04-27
Registration Number
4219862
Registration Date
2012-10-09
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) Typeset
Design Searches
260102, 261121, 280103 - Plain single line circles. Rectangles that are completely or partially shaded. Inscriptions in Chinese, Japanese, Korean, Vietnamese or other Asian characters.
Published for Opposition Date
2012-07-24
Law Office Assigned Location Code
L60
Employee Name
GOLD, BARBARA A
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Disclaimer with Predetermined Text
THE THIRD AND FOURTH CHINESE CHARACTERS THAT TRANSLATE TO "MANUFACTURE MEDICINE" OR "PHARMACEUTICAL COMPANY"
Description of Mark
The mark consists of the design of a circle with one half of the circle superimposed over a shaded rectangle, to the left of four Chinese characters over the term, "DAWNRAYS".
Goods and Services
Chemical preparations for pharmaceutical purposes for the treatment of the nervous system diseases, the immune system diseases, the cardio-vascular system diseases, the metabolic system diseases, the respiratory system diseases, the digestive system diseases, the circulatory system diseases, the urinary system diseases, the endocrine system diseases, the blood system diseases, skin disorders, gynecological diseases, ophthalmic diseases, mental disorders, inflammatory disorders, liver diseases, tumor and deficiency diseases; Pharmaceutical preparations for injection for the treatment of the nervous system diseases, the immune system diseases, the cardio-vascular system diseases, the metabolic system diseases, the respiratory system diseases, the digestive system diseases, the circulatory system diseases, the urinary system diseases, the endocrine system diseases, the blood system diseases, skin disorders, gynecological diseases, ophthalmic diseases, mental disorders, inflammatory disorders, liver diseases, tumor and deficiency diseases; Pharmaceutical preparations in tablet form for the treatment of the nervous system diseases, the immune system diseases, the cardio-vascular system diseases, the metabolic system diseases, the respiratory system diseases, the digestive system diseases, the circulatory system diseases, the urinary system diseases, the endocrine system diseases, the blood system diseases, skin disorders, gynecological diseases, ophthalmic diseases, mental disorders, inflammatory disorders, liver diseases, tumor and deficiency diseases; Chemical preparations for medical purposes for the treatment of the nervous system diseases, the immune system diseases, the cardio-vascular system diseases, the metabolic system diseases, the respiratory system diseases, the digestive system diseases, the circulatory system diseases, the urinary system diseases, the endocrine system diseases, the blood system diseases, skin disorders, gynecological diseases, ophthalmic diseases, mental disorders, inflammatory disorders, liver diseases, tumor and deficiency diseases; Prepared traditional Chinese medicines, namely, medicinal herb extracts and herb teas in preserved form for the treatment of respiratory system diseases, digestive system diseases, liver diseases, cardio-vascular system diseases and nervous system diseases; Medicines for the treatment of the nervous system diseases, the immune system diseases, the cardio-vascular system diseases, the metabolic system diseases, the respiratory system diseases, the digestive system diseases, the circulatory system diseases, the urinary system diseases, the endocrine system diseases, the blood system diseases, skin disorders, gynecological diseases, ophthalmic diseases, mental disorders, inflammatory disorders, liver diseases, tumor and deficiency diseases in humans; Medicines in capsule form for the treatment of the nervous system diseases, the immune system diseases, the cardio-vascular system diseases, the metabolic system diseases, the respiratory system diseases, the digestive system diseases, the circulatory system diseases, the urinary system diseases, the endocrine system diseases, the blood system diseases, skin disorders, gynecological diseases, ophthalmic diseases, mental disorders, inflammatory disorders, liver diseases, tumor and deficiency diseases
Pseudo Mark
DAWN RAYS
Transliteration Statement
The transliteration of the non-Latin characters in the mark is: DONG RUI ZHI YAO.
Translation of Words in Mark
The English translation of the foreign word(s) in the mark is: The first Chinese character means east, the second Chinese character means auspicious, luck, the third Chinese character means make, manufacture and the last Chinese character means medicine, drug, remedy; the combination of the first two Chinese characters has no meaning; they are Chinese trade name of the applicant; the combination of the last two Chinese characters mean pharmaceutical, pharmacy; "DAWNRAYS" appeared on the mark has no meaning in English; it is the English trade name of the applicant.
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
F - Section 71 - Cancelled
Class Status Date
2019-05-10
Primary Code
005
Correspondences
Name
CHINA TRADEMARK & P; LAW OFFICE CO., LTD
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1044202
International Registration Date
2010-04-27
International Publication Date
2010-08-12
International Renewal Date
2020-04-27
Auto Protection Date
2012-02-05
International Status
102 - Death of IR (Dead as a Result of Non-Renewal, Renunciation or Cancellation by Holder of International Registration)
International Status Date
2020-04-27
Priority Claimed In
False
First Refusal In
True
Trademark Events
Event DateEvent Description
2010-08-05SN ASSIGNED FOR SECT 66A APPL FROM IB
2010-08-06NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2010-08-08ASSIGNED TO EXAMINER
2010-08-08NON-FINAL ACTION WRITTEN
2010-08-09NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
2010-08-10APPLICATION FILING RECEIPT MAILED
2010-08-10REFUSAL PROCESSED BY MPU
2010-08-10NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
2010-09-04REFUSAL PROCESSED BY IB
2011-01-31TEAS RESPONSE TO OFFICE ACTION RECEIVED
2011-01-31CORRESPONDENCE RECEIVED IN LAW OFFICE
2011-01-31TEAS/EMAIL CORRESPONDENCE ENTERED
2011-02-21FINAL REFUSAL WRITTEN
2011-02-22FINAL REFUSAL MAILED
2011-08-10TEAS REQUEST FOR RECONSIDERATION RECEIVED
2011-08-10CORRESPONDENCE RECEIVED IN LAW OFFICE
2011-08-10TEAS/EMAIL CORRESPONDENCE ENTERED
2011-09-01APPROVED FOR PUB - PRINCIPAL REGISTER
2011-09-16ASSIGNED TO LIE
2011-09-22LAW OFFICE PUBLICATION REVIEW COMPLETED
2011-10-03WITHDRAWN FROM PUB - OG REVIEW QUERY
2011-10-06PREVIOUS ALLOWANCE COUNT WITHDRAWN
2011-10-07NON-FINAL ACTION WRITTEN
2011-10-11NON-FINAL ACTION MAILED
2012-01-11NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
2012-01-11NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
2012-01-31TEAS RESPONSE TO OFFICE ACTION RECEIVED
2012-01-31CORRESPONDENCE RECEIVED IN LAW OFFICE
2012-02-01TEAS/EMAIL CORRESPONDENCE ENTERED
2012-02-11NOTIFICATION PROCESSED BY IB
2012-02-24NON-FINAL ACTION WRITTEN
2012-02-27NON-FINAL ACTION MAILED
2012-05-21TEAS RESPONSE TO OFFICE ACTION RECEIVED
2012-05-21CORRESPONDENCE RECEIVED IN LAW OFFICE
2012-05-21TEAS/EMAIL CORRESPONDENCE ENTERED
2012-06-17APPROVED FOR PUB - PRINCIPAL REGISTER
2012-06-18LAW OFFICE PUBLICATION REVIEW COMPLETED
2012-07-04NOTICE OF PUBLICATION
2012-07-04NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
2012-07-04NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
2012-07-24PUBLISHED FOR OPPOSITION
2012-09-22NOTIFICATION PROCESSED BY IB
2012-10-09REGISTERED-PRINCIPAL REGISTER
2013-01-09FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
2013-01-28FINAL DISPOSITION PROCESSED
2013-01-28FINAL DISPOSITION NOTICE SENT TO IB
2013-02-19FINAL DECISION TRANSACTION PROCESSED BY IB
2019-05-10CANCELLED SECTION 71
2020-01-10TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
2020-01-31INVALIDATION PROCESSED
2020-01-31TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
2020-02-28TOTAL INVALIDATION PROCESSED BY THE IB
2021-05-16DEATH OF INTERNATIONAL REGISTRATION
2021-05-16NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED